Publications

All      Ay      Benedict       Cheroutre       Croft       Crotty      Einav       Grifoni       Hogan       Kronenberg      Lisdestam Arlehamn      Myers      Peters      Rao      Reina      Saphire      Schmiedel      Schoenberger      Sette      Sharma      Shresta      Vijayanand      Weiskopf

Altman             Eschweiler      Hedrick       Kawakami      Ley      Pandurangan      Seumois      Von Herrath      
07/15/2025
  • Nat Commun

Structural stabilization of the intrinsically disordered SARS-CoV-2 N by binding to RNA sequences engineered from the viral genome fragment

Landeras-Bueno S, Hariharan C, Avalos RD, Norris AS, Snyder DT, Hastie KM, Harkins S, Zandonatti M, Rajamanickam RR, Olmedillas E, Miller R, Shresta S, Wysocki VH, Saphire EO
12/01/2024
  • Microbiol Resour Announc

Genomic surveillance of SARS-CoV-2 in Nepal

Khadka B, Napit R, Mihindukulasuriya KA, Shrestha S, Rauniyar R, Tuladhar ET, Droit L, Paredes AM, Jha R, Raut R, Jha BK, Handley SA, Elong-Ngono A, Shresta S, Wang D, Manandhar KD.
02/27/2025
  • EBioMedicine

A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity.

Ana-Sosa-Batiz F, Verma SK, Shafee N, Miller R, Conner C, Hastie KM, Timis J, Maule E, Nguyen MN, Tran L, Varghese K, Madany H, Street AE, Zandonatti M, Moi ML, Jarnagin K, Webb DR, Saphire EO, Kim K, Shresta S.
02/18/2010
  • Cell Host Microbe

Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease

Zellweger RM, Prestwood TR, Shresta S
11/01/2010
  • J Immunol

CD4+ T Cells Are Not Required for the Induction of Dengue Virus-Specific CD8+ T Cell or Antibody Responses but Contribute to Protection after Vaccination

Yauch LE, Prestwood TR, May MM, Morar MM, Zellweger RM, Peters B, Sette A, Shresta S
02/01/2011
  • PLoS Pathogens

STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor

Perry ST, Buck MD, Lada SM, Schindler C, Shresta S
02/01/2011
  • Antiviral Chemistry & Chemotherapy

Important advances in the field of anti-dengue virus research

Julander JG, Perry ST, Shresta S
07/01/2011
  • Expert Review of Anti-infective Therapy

Better late than never: antivirals for dengue

Perry ST, Buck MD, Shresta S
10/01/2011
  • Journal of Virology

Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a high conserved sequence

Stein DA, Perty ST, Buck MD, Oehmen CS, Fischer MA, Poore E, Smith JL, Lancaster AM, Hirsch AJ, Slifka MK, Nelson JA, Shresta S, Fruh K
10/01/2011
  • Journal of Immunology

Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design

Weiskopf D, Yauch LE, Angelo MA, John DV, Greenbaum JA, Sidney J, Kolla RV, De Silva AD, de Silva AM, Grey H, Peters B, Shresta S, Sette A
02/01/2012
  • mBio

Role of complement in dengue virus infection: protection or pathogenesis?

Shresta S
11/01/2012
  • Journal of Virology

Trafficking and replication patterns reveal splenic macrophages as major targets of dengue virus in mice

Prestwood TR, May MM, Plummer EM, Morar MM, Yauch LE, Shresta S